Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Brian S Decker"'
Autor:
Janet S Carpenter, Marc B Rosenman, Mitchell R Knisely, Brian S Decker, Kenneth D Levy, David A Flockhart
Publikováno v:
SAGE Open Medicine, Vol 4 (2016)
Objective: Prior to implementing a trial to evaluate the economic costs and clinical outcomes of pharmacogenetic testing in a large safety net health care system, we determined the number of patients taking targeted medications and their clinical car
Externí odkaz:
https://doaj.org/article/a24949be1d9244cf899fb7ae46a02384
Autor:
Susanne B. Haga, Ebony B. Madden, Joshua C. Denny, Brian S. Decker, Kristin Weitzel, Toni I. Pollin, Aniwaa Owusu-Obeng, Eric Dietrich, John G. Gums, Barbara A. Bernhardt, Rebekah Ryanne Wu, Benjamin Q. Duong, Carol R. Horowitz, Noura S. Abul-Husn, Meghan J. Arwood
Publikováno v:
Pharmacogenomics
Pharmacogenetic testing can help identify primary care patients at increased risk for medication toxicity, poor response or treatment failure and inform drug therapy. While testing availability is increasing, providers are unprepared to routinely use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62aa2f15d5deb3d3117f26a5c1c2edf4
https://doi.org/10.2217/pgs-2019-0053
https://doi.org/10.2217/pgs-2019-0053
Autor:
Robert R. Bies, Violeta Rodriguez‐Romero, Brian S. Decker, Gezim Lahu, Richard F. Bergstrom, Majid Vakilynejad
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 5, Pp 519-528 (2019)
Clinical and Translational Science
Clinical and Translational Science
Applying data mining and machine learning (ML) techniques to clinical data might identify predictive biomarkers for diabetic nephropathy (DN), a common complication of type 2 diabetes mellitus (T2DM). A retrospective analysis of the Action to Control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59396e01637d323d6c4456cf30b841ec
https://doaj.org/article/0da24c3996ec40f793a35d311e444598
https://doaj.org/article/0da24c3996ec40f793a35d311e444598
Autor:
George Bayliss, Jason Cobb, Katlyn Leight, Nina Vasavada, Bruce A. Molitoris, Mark G. Parker, Titilayo O. Ilori, Lina Mackelaite, Brian S. Decker, Tod Ibrahim, Richard N. Hellman, Mark D. Okusa, Li-Li Hsiao, Craig Shadur
Publikováno v:
Clinical Kidney Journal
Background The American Society of Nephrology’s (ASN) Workforce Committee created a unique program called the Kidney Mentoring and Awareness Program for Students to engage medical students in the fight against kidney diseases and interest them in c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828598fe1a908fdd1f463299aaffeea1
https://doi.org/10.1093/ckj/sfz108
https://doi.org/10.1093/ckj/sfz108
Autor:
Sharon M. Moe, Howard J. Edenberg, Leah Wetherill, Tatiana Foroud, Tae Hwi Schwantes-An, Margaret R. Stedman, Matteo Vatta, Sai Liu, Brian S. Decker, Glenn M. Chertow
Publikováno v:
American Journal of Nephrology. 49:125-132
Background: Elevated serum concentrations of fibroblast growth factor 23 (FGF23) are associated with cardiovascular mortality in patients with chronic kidney disease and those undergoing dialysis. Objectives: We tested the hypotheses that polymorphis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27b2150efd9edf22730d4ec1ae53883d
https://doi.org/10.1159/000496060
https://doi.org/10.1159/000496060
Autor:
Dongbing Lai, Leah Wetherill, Brian S. Decker, Jin Long, Tatiana Foroud, Glenn M. Chertow, Matteo Vatta, Sharon M. Moe, Safa Abdalla
Publikováno v:
Clinical Journal of the American Society of Nephrology. 12:1128-1138
Background and objectives We tested the hypothesis that single nucleotide polymorphisms (SNPs) in the calcium-sensing receptor (CASR) alter the response to the calcimimetic cinacalcet. Design, setting, participants, & measurements We analyzed DNA sam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b182294b31e0df3a1c6e22ba841b4370
https://doi.org/10.2215/cjn.11141016
https://doi.org/10.2215/cjn.11141016
Publikováno v:
Journal of Renal Care. 43:209-218
SUMMARYBackground Patterns of healthcare encounters by patients in each stage of chronic kidney disease (CKD) have not been fully described. Objective This study describes patterns of healthcare resource use by patients with CKD. Design A retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::918aa7bda26c9766c3d188485821bccc
https://doi.org/10.1111/jorc.12200
https://doi.org/10.1111/jorc.12200
Autor:
Thomas Marbury, Donmienne Doen Mun Leung, Jolene Kay Berg, Juliet McColm, Matthew J. Sheetz, Robert J. Benschop, Sophie Callies, Philip Barrington, Stephanie Marie Truhlar, Paul Berg, Brian S. Decker, Gregory L. Dyas, Derrick R. Witcher
Publikováno v:
Br J Clin Pharmacol
Aims Erythropoiesis-stimulating agents used to treat anaemia in patients with chronic kidney disease (CKD) have been associated with cardiovascular adverse events. Hepcidin production, controlled by bone morphogenic protein 6 (BMP6), regulates iron h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0a56da11c27c714d19f2a3d807ce585
https://europepmc.org/articles/PMC6475730/
https://europepmc.org/articles/PMC6475730/
Autor:
Brandon T. Gufford, Zeruesenay Desta, Todd C. Skaar, Michael T. Eadon, Paul R. Dexter, Brian S. Decker, Kenneth D. Levy, Victoria M. Pratt, John T. Callaghan, Yifei Zhang, Yong Zang, Ann M. Holmes, Cathy R. Fulton, Marc B. Rosenman
Background: Tramadol and codeine are metabolized by CYP2D6 and are subject to drug–gene and drug–drug interactions. Methods: This interim analysis examined prescribing behavior and efficacy in 102 individuals prescribed tramadol or codeine while
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::689a4798b81da35ead329387dcd0e7ad
https://europepmc.org/articles/PMC6562829/
https://europepmc.org/articles/PMC6562829/
Autor:
Michael T. Eadon, Marc B. Rosenman, Kenneth D. Levy, Victoria M. Pratt, Ann M. Holmes, Brian S. Decker
Publikováno v:
Value Health
Objectives Implementing new programs to support precision medicine in clinical settings is a complex endeavor. We describe challenges and potential solutions based on the Indiana GENomics Implementation: an Opportunity for the Underserved (INGenious)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5594dabfbd043fdf8a99583cc873297
https://doi.org/10.1016/j.jval.2016.08.727
https://doi.org/10.1016/j.jval.2016.08.727